Renaissance Group’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Renaissance Group’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-12,156	Closed	-$3.96M	–	288
2024 Q1	$3.96M	Buy	12,156 +2,489	+26%	+$611K	0.15%	114
2023 Q4	$1.84M	Buy	9,667 +263	+3%	+$49.7K	0.08%	176
2023 Q3	$1.87M	Buy	9,404 +157	+2%	+$37.1K	0.09%	166
2023 Q2	$2.64M	Buy	9,247 +493	+6%	+$137K	0.11%	111
2023 Q1	$1.9M	Buy	8,754 +696	+9%	+$136K	0.09%	132
2022 Q4	$1.66M	Buy	8,058 +142	+2%	+$35.9K	0.08%	135
2022 Q3	$2.2M	Buy	7,916 +174	+2%	+$44.2K	0.12%	110
2022 Q2	$1.48M	Buy	+7,742	New	+$1.37M	0.08%	122

Other funds holding SWAV

Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return

UWS

Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Renaissance Group's SWAV Position: Q2 2024 in Review

Renaissance Group sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 12,156 shares — an estimated $3.96M sold.

Renaissance Group first reported a position in SWAV in Q2 2022 and held it in 8 quarters. The position peaked at $3.96M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

Renaissance Group reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Renaissance Group sold 12,156 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $3.96M.
Renaissance Group first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
Renaissance Group's Shockwave Medical, Inc. Common Stock position peaked at $3.96M in Q1 2024.
7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Renaissance Group's 13F filing for Q2 2024, filed 14 Aug 2024.